Passage BIO (PASG) Change in Accured Expenses (2019 - 2026)

Passage BIO's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$758000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 72.06% year-over-year to -$758000.0; the TTM figure through Mar 2026 stood at -$99000.0 (up 97.16% YoY), while the FY2025 annual figure was -$2.1 million, up 58.61% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$758000.0, down from $652000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.9 million in Q1 2023, with the low at -$4.8 million in Q1 2022.
• The 5-year median for Change in Accured Expenses is -$72000.0 (2025), against an average of -$850235.3.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses tumbled 2543.64% in 2022, then surged 3063.64% in 2025.
• Passage BIO's Change in Accured Expenses stood at -$2.3 million in 2022, then climbed by 10.28% to -$2.0 million in 2023, then surged by 98.92% to -$22000.0 in 2024, then soared by 3063.64% to $652000.0 in 2025, then slumped by 216.26% to -$758000.0 in 2026.
• Business Quant data shows PASG's Change in Accured Expenses at -$758000.0 in Q1 2026, $652000.0 in Q4 2025, and -$72000.0 in Q3 2025.